Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization
Sounni, Nor Eddine; Baramova, Eugénia; Munaut, Carineet al.
2002 • In International Journal of Cancer, 98 (1), p. 23-28
[en] Membrane-type metalloproteinase-1 (MT1-MMP) is a transmembrane metalloproteinase overexpressed in tumors, which plays a major role in the first step of pro-MMP-2 activation, leading to the generation of an intermediate 62 kDa species. The second step of MMP-2 activation that yields to the mature form is less understood and could involve an autocatalytic process and/or the activity of the plasminogen/plasmin system. Human melanoma A2058 cells, which express MMP-2 only in its pro-form, were used to determine the role of MT1-MMP during pericellular proteolysis and tumor progression. The induction of MT1-MMP overexpression by MT1-MMP cDNA transfection initiated the first step of MMP-2 activation. We provide evidence that a cooperation between the plasminogen/plasmin system and MT1-MMP endowed the cells with the ability to fully activate MMP-2 and with enhanced invasive properties in vitro. When injected subcutaneously in nude mice, MT1-MMP expressing clones induced rapid tumor growth and high tumor vascularization, while the control clones were poorly or not tumorigenic. Our data provide the first demonstration, in an experimental model, that MT1-MMP expression by tumor cells promotes tumor vascularization.
Disciplines :
Oncology
Author, co-author :
Sounni, Nor Eddine ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Baramova, Eugénia
Munaut, Carine ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Maquoi, Erik ; Université de Liège - ULiège > Département des sciences cliniques > Labo de biologie des tumeurs et du développement
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique - Labo de biologie des tumeurs et du développement
Noël, Agnès ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme
Language :
English
Title :
Expression of membrane type 1 matrix metalloproteinase (MT1-MMP) in A2058 melanoma cells is associated with MMP-2 activation and increased tumor growth and vascularization
Publication date :
01 March 2002
Journal title :
International Journal of Cancer
ISSN :
0020-7136
eISSN :
1097-0215
Publisher :
Wiley Liss, Inc., New York, United States - New York
Birkedal-Hansen H., Moore W.G., Bodden M.K. (1993) Matrix metalloproteinases: A review. Crit Rev Oral Biol Med 4:197-250.
Birkedal-Hansen H. (1995) Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735.
DeClerck Y.A. (2000) Interactions between tumour cells and stromal cells and proteolytic modification of the extracellular matrix by metalloproteinases in cancer. Eur J Cancer 36:1258-1268.
Noel A., Gilles C., Bajou K. (1997) Emerging roles for proteinases in cancer. Invasion Metastasis 17:221-239.
McCawley L.J., Matrisian L.M. (2000) Matrix metalloproteinases: Multifunctional contributors to tumor progression. Mol Med Today 6:149-156.
Curran S., Murray G.I. (2000) Matrix metalloproteinases: Molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 36:1621-1630.
Nagase H. (1997) Activation mechanisms of matrix metalloproteinases. Biol Chem 378:151-160.
Ries C., Petrides P.E. (1995) Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease. Biol Chem Hoppe Seyler 376:345-355.
Sato H., Takino T., Okada Y. (1994) A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370:61-65.
Strongin A.Y., Collier I., Bannikov G. (1995) Mechanism of cell surface activation of 72-kDa type IV collagenase: Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270:5331-5338.
Butler G.S., Butler M.J., Atkinson S.J. (1998) The TIMP2 membrane type 1 metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A: A kinetic study. J Biol Chem 273:871-880.
Atkinson S.J., Crabbe T., Cowell S. (1995) Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 270:30479-30485.
Baramova E.N., Bajou K., Remacle A. (1997) Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett 405:157-162.
Mazzieri R., Masiero L., Zanetta L. (1997) Control of type IV collagenase activity by components of the urokinase- plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J 16:2319-2332.
Ohuchi E., Imai K., Fujii Y. (1997) Membrane type 1 matrix metalloproteinase digests interstitial collagens and other extracellular matrix macromolecules. J Biol Chem 272:2446-2451.
D'Ortho M.P., Will H., Atkinson S. (1997) Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem 250:751-757.
D'Ortho M.P., Stanton H., Butler M. (1998) MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett 421:159-164.
Giannelli G., Falk-Marzillier J., Schiraldi O. (1997) Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277:225-228.
Hiraoka N., Allen E., Apel I.J. (1998) Matrix metalloproteinases regulate neovascularization by acting as pericellular fibrinolysins. Cell 95:365-377.
Holmbeck K., Bianco P., Caterina J. (1999) MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99:81-92.
Zhou Z., Apte S.S., Soininen R. (2000) Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 97:4052-4057.
Polette M., Birembaut P. (1998) Membrane-type metalloproteinases in tumor invasion. Int J Biochem Cell Biol 30:1195-1202.
Seiki M. (1999) Membrane-type matrix metalloproteinases. APMIS 107:137-143.
Belien A.T., Paganetti P.A., Schwab M.E. (1999) Membrane-type 1 matrix metalloprotease (MT1-MMP) enables invasive migration of glioma cells in central nervous system white matter. J Cell Biol 144:373-384.
Hofmann U.B., Westphal J.R., Zendman A.J. (2000) Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J Pathol 191:245-256.
Tsunezuka Y., Kinoh H., Takino T. (1996) Expression of membrane-type matrix metalloproteinase 1 (MT1-MMP) in tumor cells enhances pulmonary metastasis in an experimental metastasis assay. Cancer Res 56:5678-5683.
Davidson B., Goldberg I., Kopolovic J. (1999) MMP-2 and TIMP-2 expression correlates with poor prognosis in cervical carcinoma - A clinicopathologic study using immunohistochemistry and mRNA in situ hybridization. Gynecol Oncol 73:372-382.
Ueno H., Nakamura H., Inoue M. (1997) Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas. Cancer Res 57:2055-2060.
Maquoi E., Frankenne F., Baramova E. (2000) Membrane type 1 matrix metalloproteinase-associated degradation of tissue inhibitor of metalloproteinase 2 in human tumor cell lines. J Biol Chem 275:11368-11378.
Labarca C., Paigen K. (1980) A simple, rapid, and sensitive DNA assay procedure. Anal Biochem 102:344-352.
Noel A., Pauw-Gillet M.C., Purnell G. (1993) Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by matrigel and fibroblasts. Br J Cancer 68:909-915.
Bajou K., Noel A., Gerard R.D. (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4:923-928.
Kinoshita T., Sato H., Takino T. (1996) Processing of a precursor of 72-kilodalton type IV collagenase/gelatinase A by a recombinant membrane-type 1 matrix metalloproteinase. Cancer Res 56:2535-2538.
Will H., Atkinson S.J., Butler G.S. (1996) The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3. J Biol Chem 271:17119-17123.
Devy L., Noel A., Baramova E. (1997) Production and activation of matrix metalloprotease-9 (MMP-9) by HL-60 promyelocytic leukemia cells. Biochem Biophys Res Commun 238:842-846.
Moons L., Shi C., Ploplis V. (1998) Reduced transplant arteriosclerosis in plasminogen-deficient mice. J Clin Invest 102:1788-1797.
Hahn-Dantona E., Ramos-DeSimone N., Sipley J. (1999) Activation of proMMP-9 by a plasmin/MMP-3 cascade in a tumor cell model. Regulation by tissue inhibitors of metalloproteinases. Ann NY Acad Sci 878:372-387.
Zucker S., Drews M., Conner C. (1998) Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP). J Biol Chem 273:1216-1222.
Pulyaeva H., Bueno J., Polette M. (1997) MT1-MMP correlates with MMP-2 activation potential seen after epithelial to mesenchymal transition in human breast carcinoma cells. Clin Exp Metastasis 15:111-120.
Gilles C., Polette M., Piette J. (1996) High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 65:209-213.
Itoh T., Tanioka M., Yoshida H. (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58:1048-1051.
Bergers G., Brekken R., McMahon G. (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2:737-744.
Hotary K., Allen E., Punturieri A. (2000) Regulation of cell invasion and morphogenesis in a 3-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J cell Biol 149:1309-1323.
Koshikawa N., Giannelli G., Cirulli V. (2000) Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 148:615-624.
Deryugina E.I., Bourdon M.A., Jungwirth K. (2000) Functional activation of integrin alpha V beta 3 in tumor cells expressing membrane-type 1 matrix metalloproteinase. Int J Cancer 86:15-23.
Hendrix M.J., Seftor E.A., Meltzer P.S. (2001) Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry. Proc Natl Acad Sci USA 98:8018-8023.
